Therapieresistenz bei chronisch-entzündlichen Darmerkrankungen: Neue Biomarker für präzise Auswahl von Biologika
Author:
Publisher
Deutscher Arzte-Verlag GmbH
Reference14 articles.
1. Baumgart DC, Le Berre C: Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease. N Engl J Med 30. September 2021; 385 (14): 1302–15; DOI: 10.1056/NEJMra1907607. PMID: 34587387.
2. Jessen B, Rodriguez-Sillke Y, Sonnenberg E, Schumann M, Kruglov A, Freise I, Schmidt F, Maul J, Kühl AA, Glauben R, Lissner D, Siegmund B: Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab. Clin Gastroenterol Hepatol April 2021; 19 (4): 721–31.e1; DOI: 10.1016/j.cgh.2020.03.066. (last accessed on 6 April 2020). PMID: 32272247.
3. Verstockt B, Verstockt S, Dehairs J, Ballet V, Blevi H, Wollants WJ, Breynaert C, Van Assche G, Vermeire S, Ferrante M: Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease. EBioMedicine Februar 2019; 40: 733–42; DOI: 10.1016/j.ebiom.2019.01.027. (last accessed on 24 January 2019). PMID: 30685385; PMCID: PMC6413341.
4. Verstockt B, Verstockt S, Creyns B, Tops S, Van Assche G, Gils A, Ceuppens JL, Vermeire S, Ferrante M, Breynaert C: Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn’s disease. Aliment Pharmacol Ther März 2019; 49 (5): 572–81; DOI: 10.1111/apt.15126. (last accessed on 20 January 2019). PMID: 30663072; PMCID: PMC6849553.
5. Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, Hildner K, Waldner MJ, Mudter J, Hartmann A, Grützmann R, Neufert C, Münster T, Neurath MF, Atreya R: Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn’s disease. Gut Mai 2019; 68 (5): 814–28; DOI: 10.1136/gutjnl-2017–315671. (last accessed on 30 May 2018). PMID: 29848778; PMCID: PMC6580782.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3